Jun 26, 2018 5:30 am EDT Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction
Jun 19, 2018 4:01 pm EDT Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Jun 15, 2018 8:30 am EDT Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
Jun 11, 2018 5:30 am EDT Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules
Mar 6, 2018 5:30 am EST Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health
Mar 1, 2018 4:30 pm EST Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results
Feb 20, 2018 5:30 am EST Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study
